Skip to main content

Advertisement

SpringerLink
Log in

Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The association between vitamin D receptor (VDR) gene polymorphisms and risk of benign prostatic hyperplasia (BPH) has been investigated in numerous publications, but published results remain inconclusive. Hence, we conducted this meta-analysis to derive a more precise conclusion. Four polymorphisms (Taq-I, Bsm-I, Apa-I, and Fok-I) of the VDR gene with risk of BPH from six case–control studies and one cohort study involving 2,248 individuals were identified from PubMed and China National Knowledge Internet databases up to November 20, 2013 (updated on March 5, 2014). After data extraction, the meta-analysis was performed using Comprehensive Meta-Analysis software. All four VDR polymorphisms were not associated with the risk of BPH [Taq-I: OR 0.61, 95 % CI (0.38–1.24) for tt vs. TT; Bsm-I: OR 1.27, 95 % CI (0.96–1.69) for bb vs. BB; Apa-I: OR 1.26, 95 % CI (0.64–2.46) for aa vs. AA; Fok-I: OR 0.95, 95 % CI (0.60–1.50) for ff vs. FF]. Subgroup analysis according to ethnicity for Taq-I polymorphism also showed that the polymorphism was not associated with risk of BPH for either Caucasians [OR 0.74, 95 % CI (0.31–1.78) for tt vs. TT] or Asians [OR 0.35, 95 % CI (0.11–1.11) for tt vs. TT]. However, results of this meta-analysis should be treated with caution because this meta-analysis has several limitations. We propose to conduct a high-quality study with large sample size to further identify the association between VDR gene polymorphisms and BPH susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Roehrborn C (2008) Pathology of benign prostatic hyperplasia. Int J Impot Res 20:S11–S18

    Article  PubMed  Google Scholar 

  2. Priest R, Garzotto M, Kaufman J (2012) Benign prostatic hyperplasia: a brief overview of pathogenesis, diagnosis, and therapy. Tech Vasc Interv Radiol 15(4):261–264. doi:10.1053/j.tvir.2012.10.001

    Article  PubMed  Google Scholar 

  3. Santos Dias J (2012) Benign prostatic hyperplasia: clinical manifestations and evaluation. Tech Vasc Interv Radiol 15(4):265–269. doi:10.1053/j.tvir.2012.09.007

    Article  PubMed  Google Scholar 

  4. Larsen B, Post GJ (2013) LUTS: a practical guide to alleviating lower urinary tract symptoms. JAAPA 26(3):26–30

    PubMed  Google Scholar 

  5. Pinheiro LC, Martins Pisco J (2012) Treatment of benign prostatic hyperplasia. Tech Vasc Interv Radiol 15(4):256–260. doi:10.1053/j.tvir.2012.09.004

    Article  PubMed  Google Scholar 

  6. Luo J, Dunn T, Ewing C, Sauvageot J, Chen Y, Trent J, Isaacs W (2002) Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. Prostate 51(3):189–200

    Article  CAS  PubMed  Google Scholar 

  7. Bassil N (2012) Testicular function. Pathy’s principles and practice of geriatric medicine, vols 1, 2, 5th edn. pp 1211–1223

  8. Sanda M, Beaty T, Stutzman R, Childs B, Walsh P (1994) Genetic susceptibility of benign prostatic hyperplasia. J Urol 152(1):115–119

    CAS  PubMed  Google Scholar 

  9. Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E (2000) Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 163(2):490–495

    Article  CAS  PubMed  Google Scholar 

  10. Pearson JD, Lei H–H, Beaty TH, Wiley KE, Isaacs SD, Isaacs WB, Stoner E, Walsh PC (2003) Familial aggregation of bothersome benign prostatic hyperplasia symptoms. Urology 61(4):781–785

    Article  PubMed  Google Scholar 

  11. Negri E, Pelucchi C, Talamini R, Montella M, Gallus S, Bosetti C, Franceschi S, La Vecchia C (2005) Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia. Int J Cancer 114(4):648–652

    Article  CAS  PubMed  Google Scholar 

  12. Konwar R, Chattopadhyay N, Bid HK (2008) Genetic polymorphism and pathogenesis of benign prostatic hyperplasia. BJU Int 102(5):536–544

    Article  CAS  PubMed  Google Scholar 

  13. Geovanni Espinosa N, Esposito R, Kazzazi A, Djavan B (2013) Vitamin D and benign prostatic hyperplasia-a review. Can J Urol 20(4):6821

    Google Scholar 

  14. Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338(2):143–156

    Article  CAS  PubMed  Google Scholar 

  15. Bousema JT, Bussemakers MJ, van Houwelingen KP, Debruyne FM, Verbeek A, Kiemeney L (2000) Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol 37(2):234–238

    Article  CAS  PubMed  Google Scholar 

  16. Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y (2000) Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res 60(2):305–308

    CAS  PubMed  Google Scholar 

  17. Hamasaki T, Inatomi H, Katoh T, Ikuyama T, Matsumoto T (2002) Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese. Urol Int 68(4):226–231

    Article  CAS  PubMed  Google Scholar 

  18. Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, Thammavit W (2006) Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls. Asian Pac J Cancer Prev 7(1):136

    PubMed  Google Scholar 

  19. Huang SP, Huang CY, Wu WJ, Pu YS, Chen J, Chen YY, Yu CC, Wu TT, Wang JS, Lee YH (2006) Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy. Int J Cancer 119(8):1902–1907

    Article  CAS  PubMed  Google Scholar 

  20. Mullan RJ, Bergstralh EJ, Farmer SA, Jacobson DJ, Hebbring SJ, Cunningham JM, Thibodeau SN, Lieber MM, Jacobsen SJ, Roberts RO (2006) Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology 67(2):300–305

    Article  PubMed  Google Scholar 

  21. Manchanda PK, Konwar R, Nayak VL, Singh V, Bid HK (2010) Association of genetic variants of the vitamin D receptor (VDR) gene (Fok-I, Taq-I and Bsm-I) with susceptibility of benign prostatic hyperplasia in a North Indian population. Asian Pac J Cancer Prev 11:1005–1008

    PubMed  Google Scholar 

  22. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012

    Article  CAS  PubMed  Google Scholar 

  23. Coory MD (2010) Comment on: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 39(3):932-932

    Google Scholar 

Download references

Acknowledgments

This work was partly supported by grants from the Natural Science Foundation of China) (No. 81172734) and Foundation of Wuhan University (No. 111086), without commercial or for-profit organs. No additional external funding received for this study.

Conflict of interest

All authors declared there was none conflict of interest.

Author information

Authors and Affiliations

  1. Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, People’s Republic of China

    Xian-Tao Zeng & Hong Weng

  2. Department of Urology, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, People’s Republic of China

    Qi-Sheng Yao

  3. Department of Urology, Zhongnan Hospital, Wuhan University, 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, People’s Republic of China

    Hong Weng, Sheng Li, Jing-Yu Huang & Xing-Huan Wang

Authors
  1. Xian-Tao Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qi-Sheng Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hong Weng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sheng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jing-Yu Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xing-Huan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xing-Huan Wang.

Additional information

Xian-Tao Zeng and Qi-Sheng Yao are co-first authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Figure S1. Forest plot for Taq-I polymorphism based on tt vs. TT genetic model (TIFF 2455 kb)

Figure S2. Forest plot for Taq-I polymorphism based on tT vs. TT genetic model (TIFF 2346 kb)

Figure S3. Forest plot for Taq-I polymorphism based on (tt + TT) vs. TT genetic model (TIFF 2455 kb)

Figure S4. Forest plot for Taq-I polymorphism based on tt vs. (tT + TT) genetic model (TIFF 2458 kb)

Figure S5. Forest plot for Taq-I polymorphism based on bb vs. BB genetic model (TIFF 2032 kb)

Figure S6. Forest plot for Taq-I polymorphism based on bB vs. BB genetic model (TIFF 2067 kb)

Figure S7. Forest plot for Taq-I polymorphism based on (bb + bB) vs. BB genetic model (TIFF 2004 kb)

Figure S8. Forest plot for Taq-I polymorphism based on bb vs. (BB + Bb) genetic model (TIFF 2044 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zeng, XT., Yao, QS., Weng, H. et al. Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk. Mol Biol Rep 41, 6713–6717 (2014). https://doi.org/10.1007/s11033-014-3554-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3554-2

Keywords

Search

Navigation